Cardiovascular disease is the number one killer of women in the United States and around the world. In the United States alone, 500,000 women die each year from heart disease.

Founded by Kelly Cohen, Dino Martis, and Anoop Sathyan, Genexia aims to use explainable AI in mammography for early detection of coronary artery disease, significantly reducing deaths and reduced quality of life for women. Masu.

“Right now, 500,000 women die from heart attacks,” said Genexia CEO Martis. “In the future, we hope that innovations like ours will cut that number in half, and the world will be a better place to live.”

Genexia has attracted a lot of investor interest, and if funding is secured, it will enroll 2,000 women in a clinical trial to determine breast density and diagnose risk of coronary artery disease through information found in mammograms. Data will be collected that will be used to train explainable AI models to

”[Women] “We don’t see the symptoms that men do,” said Genexia Chairman of the Board, director of Digital Futures’ AI Biolab, and Brian H. Lowe Endowed Chair in Aerospace Engineering at the University of California College of Engineering and Applied Sciences. Mr. Cohen, who is also the head of the They undergo mammograms more often than men. With the evidence, we now have a chance. ”

Learn more about WCPO.